Mauro Maccarrone
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 301 publications
Fatty acid amide hydrolase (FAAH) inhibitor design and preclinical studies: lessons learned from BIA 10-2474 and the challenges ahead.
Journal: Expert opinion on drug discovery
Published: August 19, 2026
Endogenous Lipid Signals in Energy Homeostasis and Fibrosis.
Journal: Biomolecules
Published: July 06, 2026
Lipid Composition Drives Mutant Huntingtin Dimerization and Membrane Association: Insights from Computational Simulations.
Journal: Molecules (Basel, Switzerland)
Published: May 08, 2026
Targeting GPR18: Structural modelling, ligand discovery, and therapeutic potential in neuroinflammatory disorders.
Journal: Biochemical pharmacology
Published: February 10, 2026
Sustained Palmitoylethanolamide Infusion Restores Incentive Motivation and Synaptic Plasticity in the Tg2576 Mouse Model of Alzheimer's Disease.
Journal: Cells
Published: January 20, 2026
Anandamide modulates NOTCH1 signalling and inflammatory responses during human endometrial stromal cell decidualization.
Journal: Reproduction (Cambridge, England)
Published: January 14, 2026
Genetic characterization of the endocannabinoid system and psychiatric features in patients with migraine and medication overuse headache.
Journal: Cephalalgia : an international journal of headache
Published: July 02, 2025
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives.
Journal: Autoimmunity reviews
Published: April 28, 2025
Development of a human RPE In vitro model with AMD-like features reveals blue light-induced modulation of the endocannabinoid system.
Journal: Biochemical and biophysical research communications
Published: April 16, 2025
Bone inflammation in postmenopausal women with type 2 diabetes or obesity in relation to Wnt signaling and bone strength.
Journal: Metabolism: clinical and experimental
Published: March 14, 2025
FAAH Modulators from Natural Sources: A Collection of New Potential Drugs.
Journal: Cells
Published: February 27, 2025
Chronic palmitoylethanolamide administration via slow-release subcutaneous pellets promotes neuroprotection and mitigates neuroinflammation in the Tg2576 mouse model of Alzheimer's disease.
Journal: Frontiers in cellular neuroscience
Published: February 05, 2025
Last Updated: 09/26/2026